Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2016
The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma
Colm Keane, Clare Gould, Kimberley Jones, et al.
British Journal of Haematology
|
June 26, 2019
Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance
Joel C Wight, Mimi Yue, Colm Keane, et al.
Leukemia & Lymphoma
|
February 20, 2024
Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry
Diva Baggio, Cameron Wellard, Eliza Chung, et al.
Nature Communications
|
November 14, 2024
Dichotomous outcomes of TNFR1 and TNFR2 signaling in NK cell-mediated immune responses during inflammation
Timothy R McCulloch, Gustavo R Rossi, Louisa Alim, et al.
Oncotarget
|
November 10, 2018
Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma
Qingyan Cui, Frank Vari, Alexandre S Cristino, et al.
The Lancet. Haematology
|
December 22, 2015
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study
Colm Keane, Frank Vari, Mark Hertzberg, et al.
Leukemia
|
March 11, 2023
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study
Kate Manos, Geoffrey Chong, Colm Keane, et al.
Journal of the National Cancer Institute
|
July 10, 2025
Meeting trial eligibility in follicular lymphoma patients is associated with overall survival but not progression-free survival
Kimberly S Q Wong, Arina Martynchyk, Zoe Krisnadi, et al.
Blood Advances
|
June 22, 2021
Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma
Karthik Nath, Soi-Cheng Law, Muhammed B Sabdia, et al.
Blood Advances
|
June 20, 2025
T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a Phase I trial
Eliza A Hawkes, Jodie Palmer, Richard Khor, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2016
The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma
Colm Keane, Clare Gould, Kimberley Jones, et al.
British Journal of Haematology
|
June 26, 2019
Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance
Joel C Wight, Mimi Yue, Colm Keane, et al.
Leukemia & Lymphoma
|
February 20, 2024
Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry
Diva Baggio, Cameron Wellard, Eliza Chung, et al.
Nature Communications
|
November 14, 2024
Dichotomous outcomes of TNFR1 and TNFR2 signaling in NK cell-mediated immune responses during inflammation
Timothy R McCulloch, Gustavo R Rossi, Louisa Alim, et al.
Oncotarget
|
November 10, 2018
Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma
Qingyan Cui, Frank Vari, Alexandre S Cristino, et al.
The Lancet. Haematology
|
December 22, 2015
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study
Colm Keane, Frank Vari, Mark Hertzberg, et al.
Leukemia
|
March 11, 2023
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study
Kate Manos, Geoffrey Chong, Colm Keane, et al.
Journal of the National Cancer Institute
|
July 10, 2025
Meeting trial eligibility in follicular lymphoma patients is associated with overall survival but not progression-free survival
Kimberly S Q Wong, Arina Martynchyk, Zoe Krisnadi, et al.
Blood Advances
|
June 22, 2021
Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma
Karthik Nath, Soi-Cheng Law, Muhammed B Sabdia, et al.
Blood Advances
|
June 20, 2025
T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a Phase I trial
Eliza A Hawkes, Jodie Palmer, Richard Khor, et al.
Page
of 7